Therefore, this study provides a simple and effective strategy for the development of albumin–cyanine dye complexes to enhance the water stability, biocompatibility, and tumor targeting specificity of many different polymethine cyanine dyes for future clinical use. The gene discussed is ALB; the disease is neoplasm.